Table 2.
SSRI prescription | Non-pharmacological treatment | |||
Rate per 100 | Adjusted RR | Rate per 100 | Adjusted RR | |
Age group | ||||
15–19 | 18.8 (18.0 to 19.5) | 1.78 (1.68 to 1.88) | 4.9 (4.5 to 5.4) | 1.55 (1.41 to 1.72) |
20–24 | 15.9 (15.5 to 16.4) | 1.54 (1.47 to 1.61) | 4.4 (4.1 to 4.6) | 1.38 (1.28 to 1.49) |
25–29 | 11.7 (11.5 to 12.0) | 1.18 (1.14 to 1.23) | 3.3 (3.2 to 3.5) | 1.11 (1.04 to 1.18) |
30–34 | 9.6 (9.4 to 9.8) | 1 | 2.9 (2.8 to 3.0) | 1 |
35–39 | 9.3 (9.1 to 9.6) | 0.99 (0.95 to 1.03) | 2.9 (2.7 to 3.0) | 0.99 (0.92 to 1.07) |
40–49 | 9.6 (9.0 to 10.1) | 1.01 (0.94 to 1.07) | 3.1 (2.7 to 3.4) | 1.05 (0.93 to 1.19) |
Calendar period | ||||
2000–2004 | 11.4 (11.1 to 11.7) | 1 | 2.4 (2.2 to 2.5) | 1 |
2005–2009 | 11.3 (11.1 to 11.6) | 0.97 (0.93 to 1.01) | 3.5 (3.3 to 3.6) | 1.43 (1.30 to 1.57) |
2010–2013 | 11.5 (11.2 to 11.7) | 0.96 (0.92 to 1.01) | 3.8 (3.6 to 3.9) | 1.54 (1.38 to 1.71) |
Townsend Deprivation Index quantile | ||||
1 | 8.9 (8.7 to 9.2) | 1 | 2.7 (2.5 to 2.8) | 1 |
2 | 10.0 (9.7 to 10.3) | 1.09 (1.04 to 1.14) | 3.0 (2.9 to 3.2) | 1.10 (1.00 to 1.20) |
3 | 11.3 (11.0 to 11.6) | 1.19 (1.14 to 1.25) | 3.3 (3.1 to 3.4) | 1.14 (1.04 to 1.25) |
4 | 13.1 (12.7 to 13.4) | 1.33 (1.25 to 1.40) | 3.8 (3.6 to 4.0) | 1.29 (1.17 to 1.42) |
5 | 15.2 (14.8 to 15.6) | 1.47 (1.38 to 1.57) | 4.2 (3.9 to 4.4) | 1.36 (1.22 to 1.52) |
Adjusted by age group, calendar period and Townsend Deprivation Index.
RR, relative risk; SSRI, selective serotonin reuptake inhibitor.